ニュース

Imperial College London is establishing a research and innovation hub in Bengaluru, its fourth international location. This ...
Bay Area News Group: Live Organ Donations Are Growing In The U.S., California And Bay Area, But So Is The Need Since 2014, more than 500,000 people in the U.S. have donated organs, 200,000 of ...
It is now illegal to publish or threaten to publish real or AI-generated intimate images of a person without their consent. Tech sites and companies also must take down such images within 48 hours of ...
FusionLayer, a leading innovator in cloud infrastructure solutions, proudly announces its membership in the Open Programmable Infrastructure (OPI) Project, fostering an open ecosystem for ...
Arvind Kejriwal's Aam Aadmi Party (AAP) launched ASAP, the Association of Students for Alternative Politics, aiming to engage ...
Spacs are experiencing something of a comeback thanks to the Lutnick empire, which is now led by Howard’s children and a triumvirate of bankers including infamous healthcare dealmaker Sage Kelly .
This World EoE Day – the first ever – we’re encouraging people around the globe to spread awareness of EoE and talk to a doctor if they recognize symptoms of EoE in themselves or a loved one.” — Mary ...
BioRewards Plasma Services ("BioRewards"), a next-generation plasma collection company, has officially launched with the backing of Alpha-1 Plasma Holdings ("Alpha-1"), a premier investor in plasma ...
Novo Nordisk announced it will work with the biotech Septerna to develop oral GLP-1 obesity drugs in a deal worth up to $2.2 ...
We recently compiled a list of the 11 Cheap ESG Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) stands ...
in healthcare, aiming to ensure that AI technologies are safe, ethical, and accessible—especially in low- and middle-income countries (LMICs). Study: Global Initiative on AI for Health (GI-AI4H): ...
Regeneron Pharmaceuticals ... exceeding $570 million. 1Cell.Ai and BioSkryb announced a partnership. Havas announced a strategic investment in Ostro, an agentic AI company for life sciences. VelaVigo, ...